Medicine and Dentistry
Patient
100%
Pancreas Cancer
81%
Combination Therapy
78%
Neoplasm
50%
Pancreas Adenocarcinoma
45%
Therapeutic Procedure
41%
Inpatient
40%
Biological Marker
38%
Head and Neck Cancer
36%
Cancer Cell
34%
Malignant Neoplasm
32%
Chemotherapy
26%
Age
25%
Head
22%
Cancer Therapy
22%
Surgery
21%
Neck
21%
Toxicity
21%
Cells
20%
Analysis
19%
Survival
18%
Squamous Cell
18%
Epidermal Growth Factor Receptor
18%
Cancer Associated Fibroblast
18%
Pancreatic Ductal Adenocarcinoma
18%
Protein
17%
Chemoradiotherapy
15%
Glycoprotein Gp 100
14%
Chemotherapeutic Agent
14%
Drug
14%
Lymph Node
12%
Monoclonal Antibody
12%
Molecular Profiling
12%
Cytotechnology
12%
Lymphoproliferative Disease
12%
Cytotoxic Agent
12%
Cancer
12%
Cancer Pathobiology
12%
Cell Growth
12%
Solid Malignant Neoplasm
12%
Targeted Therapy
11%
Antibody
11%
Disease
11%
Colorectal Cancer
10%
Cetuximab
10%
BRCA1
10%
Growth
10%
Cancer Growth
10%
Comprehension
9%
Epidermal Growth Factor Receptor
9%
Biochemistry, Genetics and Molecular Biology
Mutation
29%
Protein
29%
Antibody
28%
Cancer Cell
26%
Nested Gene
25%
Epidermal Growth Factor Receptor
21%
Clinical Trial
20%
Fibroblast
19%
Cell Growth
18%
Regulatory Mechanism
18%
Cholesterol Synthesis
18%
Small Molecule
16%
Development
15%
DNA Repair
12%
DNA
12%
Signaling Protein
12%
Growth
12%
Cell Cycle
11%
Lipid
11%
Aurora A Kinase
10%
Comprehension
10%
Survival
10%
Metabolite
10%
Next Generation Sequencing
9%
Genetics
9%
Sterol
9%
STIM2
9%
Centrosome
9%
Cell Division
9%
Chemosensitivity
9%
Phospholipid Scramblase
9%
Autoantibody
9%
Monoclonal Antibody
9%
Wild Type
9%
Age
9%
Wart Virus
9%
Y-27632
9%
Protein Degradation
9%
Retinoblastoma
9%
Insulin-Like Growth Factor 1
9%
Unfolded Protein Response
9%
Netrin
9%
Liver X Receptor
9%
Prostaglandin
9%
Mouse
9%
Cell Aging
9%
Dehydrogenase
9%
Cas9
9%
Steroid
9%
CRISPR
9%
Pharmacology, Toxicology and Pharmaceutical Science
Head and Neck Cancer
27%
Antibody
20%
Squamous Cell Carcinoma
20%
Monoclonal Antibody
19%
DNA
19%
Pancreas Cancer
18%
Chemotherapy
13%
Epidermal Growth Factor
12%
Receptor
11%
Malignant Neoplasm
10%
Neoplasm
10%
Cetuximab
9%
Esophagus Cancer
9%
Disease Course
9%
Lymphoproliferative Disease
9%
Epidermal Growth Factor Receptor
9%
Raf Protein
9%
Autoantibody
9%
Chronic Lymphatic Leukemia
9%
Pancreas Cancer
9%
Fitness
9%
Stomach Cancer
9%
Cancer Model
9%
Drug Conjugate
9%
Metastatic Colorectal Cancer
9%
Mepacrine
9%
Capecitabine
9%
Biological Marker
9%
Neuroendocrine Tumor
9%
Neuroendocrine Carcinoma
9%
Vandetanib
9%
Malignant Neoplasm
9%
Bosutinib
7%
Diseases
6%
Survival
6%
Catalytic Antibody
5%
Overall Survival
5%